Pfizer Market Cap 2006-2019 | PFE

Pfizer market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Pfizer market cap as of April 06, 2020 is $186.62B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $186.623B $51.750B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $353.719B 15.46
Roche Holding AG (RHHBY) Switzerland $281.610B 0.00
Merck (MRK) United States $193.391B 14.69
Novartis AG (NVS) Switzerland $191.686B 15.96
Novo Nordisk (NVO) Denmark $141.701B 24.33
Eli Lilly (LLY) United States $133.660B 23.12
Bristol-Myers Squibb (BMY) United States $125.360B 11.89
AstraZeneca (AZN) United Kingdom $115.367B 24.84
Sanofi (SNY) France $112.261B 13.34
AbbVie (ABBV) United States $108.343B 8.21
GlaxoSmithKline (GSK) United Kingdom $92.675B 11.75
Bayer (BAYRY) Germany $53.491B 7.71
H Lundbeck (HLUYY) Denmark $5.974B 10.38
Innoviva (INVA) United States $1.170B 8.08